ASCO GUIDELINES Bundle

Cancer-associated Anemia Erythropoiesis-Stimulating Agents

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475453

Contents of this Issue

Navigation

Page 4 of 5

Table 3. Estimated Prices of ESAs and Supplemental Iron Agent HCPCS Code Dosage Medicare Payment Limit ($USD) Initial Dose Regimen Price Darbepoetin alfa (non- esrd) 1 µg 3.779 2.25 µg/kg SC Weekly (SC) $1785.58 a per 3-week cycle 500 µg SC Every 3 weeks (SC) $1889.50 per 3-week cycle Epoetin alfa (non-esrd) 1000 U 13.333 150 U/kg 3 times weekly (SC) $1259.97 a per 3-week cycle 40,000 U Weekly (SC) $1599.96 per 3-week cycle Iron dextran 50 MG 13.669 Variable IV $273.38 per 1000 mg Ferric gluconate 12.5 MG 2.179 Variable IV $174.32 per 1000 mg Iron sucrose 1 MG 0.234 Variable IV $234.00 per 1000 mg Ferrous sulfate N/A N/A Variable oral Available over-the- counter. Prices at a sample of online retailers ranged from $0.01–$0.11 per 325 mg tablet a Based on a 70 kg adult. NOTE. Drug prices were estimated from a third-party payor perspective, based on reimbursement rates from the Centers for Medicare and Medicaid Services that are widely accepted by providers, computed at the manufacturer's average sales price. Other treatment-related direct and indirect costs were not considered, such as diagnostic laboratory tests. Actual treatment costs and reimbursement will vary considerably across regions, payors, institutions, and practices, as well as over time, and the reader should consult current local cost information specific to their practice setting. Costs were based on Medicare Part B payment allowance limits effective July 1, 2018 (with no administration fees or other adjustments); Medicare Part B Drug Average Sales Price: https://www.cms.gov/Medicare/Medicare-Fee- for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/2018ASPFiles.html

Articles in this issue

Links on this page

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Cancer-associated Anemia Erythropoiesis-Stimulating Agents